Journal article

Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury

M Cai, ZM Huttinger, H He, W Zhang, F Li, LA Goodman, DG Wheeler, LJ Druhan, JL Zweier, KM Dwyer, G He, AJF d'Apice, SC Robson, PJ Cowan, RJ Gumina

Journal of Molecular and Cellular Cardiology | ELSEVIER SCI LTD | Published : 2011

Abstract

Modulation of purinergic signaling is critical to myocardial homeostasis. Ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD-1; CD39) which converts the proinflammatory molecules ATP or ADP to AMP is a key regulator of purinergic modulation. However, the salutary effects of transgenic over expression of ENTPD-1 on myocardial response to ischemic injury have not been tested to date. Therefore we hypothesized that ENTPD-1 over expression affords myocardial protection from ischemia-reperfusion injury via specific cell signaling pathways. ENTPD-1 transgenic mice, which over express human ENTPDase-1, and wild-type (WT) littermates were subjected to either ex vivo or in vivo ischemia-reperfus..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Institutes of Health


Funding Acknowledgements

This work was supported by National Institutes of Health, National Heart, Lung, and Blood Institute Grants K08-HL094703 and R21-HL096038, an American Heart Association-Great Rivers Affiliate Student Undergraduate Research Fellowship Grant 10UFEL4180090 (ZMH, HH and LAG), the Davis Heart and Lung Research Institute and Ross Academic Advisory Committee (RJG).